17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease

Neurobiology of Disease

Volumn 41, Issue 2, 2011, Pages 308-317

  Massone, Sara ^a,b   Vassallo, Irene ^a,b   Fiorino, Gloria ^c   Castelnuovo, Manuele ^a,b   Barbieri, Federica ^a   Borghi, Roberta ^d   Tabaton, Massimo ^d   Robello, Mauro ^a   Gatta, Elena ^a   Russo, Claudio ^e   Florio, Tullio ^a   Dieci, Giorgio ^c   Cancedda, Ranieri ^a,b   Pagano, Aldo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF MOLISE   (Italy)

Author keywords

Amyloid ; Inflammation; Neurodegeneration; RNA polymerase III

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 51; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; POTASSIUM CHANNEL; RNA POLYMERASE II; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; NEUROBLASTOMA CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ALZHEIMER DISEASE; BASE SEQUENCE; CELL LINE, TUMOR; HELA CELLS; HUMANS; INFLAMMATION MEDIATORS; MOLECULAR SEQUENCE DATA; RECEPTORS, GABA-A; RNA POLYMERASE III; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 78650594380     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.09.019     Document Type: Article

References (21)

1. Artamonova I.I., Gelfand M.S. Comparative genomics and evolution of alternative splicing: the pessimists' science. Chem. Rev. 2007, 107:3407-3430.
2. Barbieri F., et al. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2. Endocrinology 2008, 149:4736-4746.
3. Biedler J.L., et al. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973, 33:2643-2652.
4. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 2003, 72:291-336.
5. Bowery N.G. GABAB receptor pharmacology. Annu. Rev. Pharmacol. Toxicol. 1993, 33:109-147.
6. Castelnuovo M., et al. An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. FASEB J. 2010, 24:4033-4046.
7. Davies C.H., et al. CGP 55845A: a potent antagonist of GABAB receptors in the CA1 region of rat hippocampus. Neuropharmacology 1993, 32:1071-1073.
8. Dieci G., et al. The expanding RNA polymerase III transcriptome. Trends Genet. 2007, 23:614-622.
9. Einstein R., et al. Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5230-5235.
10. Garcia-Blanco M.A., et al. Alternative splicing in disease and therapy. Nat. Biotechnol. 2004, 22:535-546.
11. Johnson S.A., et al. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science 1990, 248:854-857.
12. Pagano A., et al. New small nuclear RNA gene-like transcriptional units as sources of regulatory transcripts. PLoS Genet. 2007, 3:e1.
13. Robello M., et al. Regulation of GABAA receptor in cerebellar granule cells in culture: differential involvement of kinase activities. Neuroscience 1993, 53:131-138.
14. Roberts D.C. Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction. Physiol. Behav. 2005, 86:18-20.
15. Rogawski M.A., Wenk G.L. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Rev. 2003, 9:275-308.
16. Seamon K.B., Daly J.W. Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Protein Phosphor. Res. 1986, 20:1-150.
17. Selkoe D.J. Deciphering Alzheimer's disease: the amyloid precursor protein yields new clues. Science 1990, 248:1058-1060.
18. Sun D., et al. Regulation by nicotine of Gpr51 and Ntrk2 expression in various rat brain regions. Neuropsychopharmacology 2007, 32:110-116.
19. Wang E.T., et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
20. Wilhelm B.T., et al. Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution. Nature 2008, 453:1239-1243.
21. Wu L., et al. Novel small-molecule inhibitors of RNA polymerase III. Eukaryot. Cell 2003, 2:256-264.